Uncategorized
FDA plans to streamline regulatory processes for drugs, devices
FDA announced today that it will soon unveil a comprehensive plan referred to as the Innovative Initiative. The goal of the initiative is to ensure the efficacy of the FDA’s regulatory processes so safe and effective new technologies can reach patients in a timely fashion.“We need to make sure that our regulatory principles are efficient and informed by the most up to date science,” Scott Gottlieb, MD, commissioner of the FDA, wrote in the FDA’s blog. “We don’t want to present regulatory barriers to beneficial new medical innovations that add (Read more...)